ARDT Stock Up 24% after 8-Day Win Streak
Ardent Health (ARDT) stock hit day 8 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 24% return. The company has gained about $420 Mil in value over the last 8 days, with its current market capitalization at about $1.8 Bil. The stock remains 25.8% below its value at the end of 2024. This compares with year-to-date returns of 9.9% for the S&P 500.
ARDT is the fourth largest privately held, for-profit hospital operator and a leading provider of healthcare services in the United States.
Comparing ARDT Stock Returns With The S&P 500
The following table summarizes the return for ARDT stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | ARDT | S&P 500 |
|---|---|---|
| 1D | 1.6% | 0.3% |
| 8D (Current Streak) | 24.0% | 3.7% |
| 1M (21D) | -9.0% | 3.6% |
| 3M (63D) | -12.7% | 9.9% |
| YTD 2025 | -25.8% | 9.9% |
| 2024 | 23.3% | |
| 2023 | 24.2% | |
| 2022 | -19.4% |
What is the point? Momentum often precedes conviction. A multi-day win streak can signal growing investor confidence or spark follow-on buying. Tracking such trends can help you ride the strength, or prepare for a well-timed entry if momentum fades.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 114 S&P constituents with 3 days or more of consecutive gains and 11 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 49 | 2 |
| 4D | 33 | 5 |
| 5D | 20 | 3 |
| 6D | 5 | 0 |
| 7D or more | 7 | 1 |
| Total >=3 D | 114 | 11 |
Key Financials for Ardent Health (ARDT)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $5.4 Bil | $6.0 Bil |
| Operating Income | $224.3 Mil | $405.8 Mil |
| Net Income | $53.9 Mil | $210.3 Mil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ1 | 2025 FQ2 |
|---|---|---|
| Revenues | $1.5 Bil | $1.6 Bil |
| Operating Income | $67.1 Mil | $137.3 Mil |
| Net Income | $41.4 Mil | $73.0 Mil |
While ARDT stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.